Breast Cancer Incidence Among Black Women May Vary Substantially by Birthplace

There is substantial variation in the prevalence of triple-negative breast cancer among black women by birthplace, affirming that incidence of the disease among black women is not generalizable, according to a new study published in Cancer.
 
Triple-negative breast cancer that is negative for estrogen receptor, progesterone receptor, and human epidermal growth factor 2 receptor, is approximately twice as common among black women than white women in the United States. However, black populations in the United States are diverse and incidence rates may differ by birthplace, the researchers noted.
 
For the study, the authors examined the prevalence of triple-negative and hormone receptor-negative breast cancer among black women in the National Program of Cancer Registries and US Cancer Statistics. Overall, the authors identified 65,211 non-Hispanic black women who were diagnosed with invasive breast cancer from 2010 to 2015. Varying birthplaces in the United States, East Africa, West Africa, or the Caribbean were reported.
 
Compared with US-born black women, the prevalence rate ratio of triple-negative breast cancer was 8% lower among Western-African-born women, 13% lower among Caribbean-born women, and 46% lower among Eastern-African-born black women, according to the study.
 
Examining nativity-related differences among black women can help foster a better understanding of the etiologic heterogeneity of breast cancer, the researchers noted.
 
“It is not clear what risk factors conferred by birthplace are associated with subtype prevalence,” lead study author Hyuna Sun, PhD, of the American Cancer Society, said in a press release. “However, the similarity in breast cancer subtype prevalence between US-born and Western-African-born blacks, contrasted against the differences with Eastern-African-born blacks, may in part reflect shared ancestry-related risk factors.”
 
Despite a previous understanding of the higher proportional burden of breast cancer among black women, the researchers suggested that this notion is not reflective of the diverse black population. Furthermore, a more complete collection of birthplace information in cancer registries can help improve the specificity of understanding potential ancestry-related risk factors.
 
“These findings underscore the importance of considering geographic origin in studies characterizing breast cancer among women of African descent in the United States and elsewhere,” the researchers concluded in the study.
 
References
 
Sung H, DeSantis CE, Fedewa SA, et al. Breast cancer subtypes among Eastern-African-born black women and other black women in the United States. Cancer. 2019. Doi: https://doi.org/10.1002/cncr.32293
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Related Articles

A specialty pharmacy’s specific expertise and experience in supporting patients with cancer is among its most essential attributes.
A novel potential biomarker test could identify patients who would benefit from more advanced lung cancer screening.
In addition to a natural variation in genetic makeup, approximately 1 in 1000 people inherit a damaged or mutated copy of the BRCA1 gene from a parent.
Company Profile >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2019
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$